Jeffrey S. Wasser

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

David J. Kuter, James B. Bussel, Roger M. Lyons et al. · The Lancet · 2008 · 851 citations

Thrombopoiesis, Thrombosis, Autoimmune Disease +9

AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP

James B. Bussel, David J. Kuter, James N. George et al. · New England Journal of Medicine · 2006 · 526 citations · Full text

Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)

Tara C. Mitchell, Omid Hamid, David C. Smith et al. · Journal of Clinical Oncology · 2018 · 378 citations · Full text

Recurrent Urinary Tract Infections in Postmenopausal Women

Raanan Raz, Y. Gennesin, Jeffrey S. Wasser et al. · Clinical Infectious Diseases · 2000 · 320 citations

Urological Research, Urology, Vulvar Diseases +15

Long‐term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy

David J. Kuter, James B. Bussel, Adrian C. Newland et al. · British Journal of Haematology · 2013 · 270 citations · Full text